Genetics of Glaucoma

Abstract

Glaucoma is the major cause of blindness worldwide. Primary open‐angle glaucoma (POAG) and angle closure glaucoma (ACG) are the most prevalent forms of glaucoma and are the most common causes of glaucoma‐related blindness worldwide. It has become increasingly clear that a host of genetic and environmental factors contribute to the glaucoma phenotype. The genetic discussion covered in this review includes POAG, pigment dispersion glaucoma (PDG), exfoliation glaucoma (XFG), childhood glaucomas and angle closure glaucoma. Numerous chromosomal loci and genetic associations have been reported for different types of glaucoma. This article examines the current status of investigations into the genetic architecture of the glaucomas and how this evolving understanding may contribute to the clinical management of patients with this disease.

Key Concepts:

  • Glaucoma is characterised by the progressive loss of retinal ganglion cells that is associated with a characteristic optic neuropathy and visual field loss.

  • POAG (primary open‐angle glaucoma) is the most common type of glaucoma and is characterised by the presence of glaucomatous optic neuropathy without an identifiable secondary cause.

  • XFG (exfoliation glaucoma) is the most common identifiable form of open‐angle glaucoma.

  • PCG (primary congenital glaucoma) is the most common childhood glaucoma with a developmental abnormality of the anterior chamber angle.

  • Genetic linkage analysis has been widely used to search for genes that account for Mendelian diseases inherited as either autosomal dominant or recessive traits.

  • Genetic admixture mapping is widely used to localise disease‐associated genetic variants that differ in prevalence across populations.

  • Genome‐wide association study (GWAS) is a powerful method used to identify common genetic variants that are associated with the specific diseases or trait.

  • Genetic association analysis has been widely used to determine whether a genetic variant is associated with a disease or trait.

Keywords: glaucoma; POAG; XFG; PCG; genetics; LOXL1; myocilin; optineurin; NTF4; CYP1B1

Figure 1.

Congenital glaucoma demonstrating typical buphthalmos (Courtesy David Wallace, MD, Duke Eye Center).

Figure 2.

Axenfeld–Rieger syndrome with iris anomalies (Courtesy David Wallace, MD, Duke Eye Center).

Figure 3.

Peter's anomalies with central corneal clouding (Courtesy David Wallace, MD, Duke Eye Center).

close

References

Allingham RR, Liu Y and Rhee DJ (2009) The genetics of primary open‐angle glaucoma: a review. Experimental Eye Research 88: 837–844.

Alward WL, Fingert JH, Coote MA et al. (1998) Clinical features associated with mutations in the chromosome 1 open‐angle glaucoma gene (GLC1A). New England Journal of Medicine 338: 1022–1027.

Aung T, Rezaie T, Okada K et al. (2005) Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene. Investigative Ophthalmology and Visual Science 46: 2816–2822.

Bialasiewicz AA, Wali U, Shenoy R and Al‐Saeidi R (2005) Patients with secondary open‐angle glaucoma in pseudoexfoliation (PEX) syndrome among a population with high prevalence of PEX. Clinical findings and morphological and surgical characteristics. Ophthalmologe 102: 1064–1068.

Bilguvar K, Ozturk AK, Louvi A et al. (2010) Whole‐exome sequencing identifies recessive WDR62 mutations in severe brain malformations. Nature 467: 207–210.

Chakrabarti S, Kaur K, Kaur I et al. (2006) Globally, CYP1B1 mutations in primary congenital glaucoma are strongly structured by geographic and haplotype backgrounds. Investigative Ophthalmology and Visual Science 47: 43–47.

Chen H, Chen LJ, Zhang M et al. (2010) Ethnicity‐based subgroup meta‐analysis of the association of LOXL1 polymorphisms with glaucoma. Molecular Vision 16: 167–177.

Cornelis MC, Agrawal A, Cole JW et al. (2010) The gene, environment association studies consortium (GENEVA): maximizing the knowledge obtained from GWAS by collaboration across studies of multiple conditions. Genetic Epidemiology 34: 364–372.

Fan BJ, Wang DY, Lam DS and Pang CP (2006) Gene mapping for primary open angle glaucoma. Clinical Biochemistry 39: 249–258.

Ferrell G, Lu M, Stoddard P et al. (2009) A single nucleotide polymorphism in the promoter of the LOXL1 gene and its relationship to pelvic organ prolapse and preterm premature rupture of membranes. Reproductive Sciences 16: 438–446.

Fujikawa K, Iwata T, Inoue K et al. (2010) VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans. PLoS ONE 5: e9050.

Gould DB and John SW (2002) Anterior segment dysgenesis and the developmental glaucomas are complex traits. Human Molecular Genetics 11: 1185–1193.

Gould DB, Reedy M, Wilson LA et al. (2006) Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma. Molecular and Cellular Biology 26: 8427–8436.

Gould DB, Smith RS and John SW (2004) Anterior segment development relevant to glaucoma. International Journal of Developmental Biology 48: 1015–1029.

Hauser MA, Allingham RR, Linkroum K et al. (2006) Distribution of WDR36 DNA sequence variants in patients with primary open‐angle glaucoma. Investigative Ophthalmology and Visual Science 47: 2542–2546.

Herndon LW, Challa P, Ababio‐Danso B et al. (2002) Survey of glaucoma in an eye clinic in Ghana, West Africa. Journal of Glaucoma 11: 421–425.

Hewitt AW, Mackey DA and Craig JE (2008) Myocilin allele‐specific glaucoma phenotype database. Human Mutation 29: 207–211.

Hoffman EA, Perkumas KM, Highstrom LM and Stamer WD (2009) Regulation of myocilin‐associated exosome release from human trabecular meshwork cells. Investigative Ophthalmology and Visual Science 50: 1313–1318.

Hoischen A, van Bon BW, Gilissen C et al. (2010) De novo mutations of SETBP1 cause Schinzel‐Giedion syndrome. Nature Genetics 42: 483–485.

Kwon YH, Fingert JH, Kuehn MH and Alward WL (2009) Primary open‐angle glaucoma. New England Journal of Medicine 360: 1113–1124.

Libby RT, Gould DB, Anderson MG and John SW (2005) Complex genetics of glaucoma susceptibility. Annual Review of Genomics and Human Genetics 6: 15–44.

Liu Y, Liu W, Crooks K et al. (2010) No evidence of association of heterozygous NTF4 mutations in patients with primary open‐angle glaucoma. American Journal of Human Genetics 86: 498–499, author reply 500.

Liu Y, Schmidt S, Qin X et al. (2008) Lack of association between LOXL1 variants and primary open‐angle glaucoma in three different populations. Investigative Ophthalmology and Visual Science 49: 3465–3468.

Liu Y, Schmidt S, Qin X et al. (2007) No association between OPA1 polymorphisms and primary open‐angle glaucoma in three different populations. Molecular Vision 13: 2137–2141.

Manolio TA (2010) Genomewide association studies and assessment of the risk of disease. New England Journal of Medicine 363: 166–176.

De Marco N, Buono M, Troise F and Diez‐Roux G (2006) Optineurin increases cell survival and translocates to the nucleus in a Rab8‐dependent manner upon an apoptotic stimulus. Journal of Biological Chemistry 281: 16147–16156.

Maruyama H, Morino H, Ito H et al. (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465: 223–226.

Meguro A, Inoko H, Ota M, Mizuki N and Bahram S (2010) Genome‐wide association study of normal tension glaucoma: common variants in SRBD1 and ELOVL5 contribute to disease susceptibility. Ophthalmology 117: 1331–1338, e5.

Monemi S, Spaeth G, DaSilva A et al. (2005) Identification of a novel adult‐onset primary open‐angle glaucoma (POAG) gene on 5q22.1. Human Molecular Genetics 14: 725–733.

Morton S, Hesson L, Peggie M and Cohen P (2008) Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma. FEBS Letters 582: 997–1002.

Nakano M, Ikeda Y, Taniguchi T et al. (2009) Three susceptible loci associated with primary open‐angle glaucoma identified by genome‐wide association study in a Japanese population. Proceedings of the National Academy of Sciences of the USA 106: 12838–12842.

Pasutto F, Matsumoto T, Mardin CY et al. (2009) Heterozygous NTF4 mutations impairing neurotrophin‐4 signaling in patients with primary open‐angle glaucoma. American Journal of Human Genetics 85: 447–456.

Polansky JR, Fauss DJ, Chen P et al. (1997) Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica 211: 126–139.

Quigley HA and Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 90: 262–267.

Rao KN, Kaur I, Parikh RS et al. (2010) Variations in NTF4, VAV2 and VAV3 genes are not involved with primary open angle and primary angle closure glaucomas in an Indian population. Investigative Ophthalmology and Visual Science 51: 4937–4941.

Rezaie T, Child A, Hitchings R et al. (2002) Adult‐onset primary open‐angle glaucoma caused by mutations in optineurin. Science 295: 1077–1079.

Ritch R and Schlotzer‐Schrehardt U (2001) Exfoliation (pseudoexfoliation) syndrome: toward a new understanding. Proceedings of the First International Think Tank. Acta Ophthalmologica Scandinavica 79: 213–217.

Schlotzer‐Schrehardt U (2009) Molecular pathology of pseudoexfoliation syndrome/glaucoma–new insights from LOXL1 gene associations. Experimental Eye Research 88: 776–785.

Schlotzer‐Schrehardt U and Naumann GO (2006) Ocular and systemic pseudoexfoliation syndrome. American Journal of Ophthalmology 141: 921–937.

Schlotzer‐Schrehardt U, Pasutto F, Sommer P et al. (2008) Genotype‐correlated expression of lysyl oxidase‐like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. American Journal of Pathology 173: 1724–1735.

Senatorov V, Malyukova I, Fariss R et al. (2006) Expression of mutated mouse myocilin induces open‐angle glaucoma in transgenic mice. Journal of Neuroscience 26: 11903–11914.

Stoilov I, Akarsu AN and Sarfarazi M (1997) Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Human Molecular Genetics 6: 641–647.

Stone EM, Fingert JH, Alward WL et al. (1997) Identification of a gene that causes primary open angle glaucoma. Science 275: 668–670.

Teer JK and Mullikin JC (2010) Exome sequencing: the sweet spot before whole genomes. Human Molecular Genetics 19: R145–R151.

Thorleifsson G, Magnusson KP, Sulem P et al. (2007) Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 317: 1397–1400.

Vasiliou V and Gonzalez FJ (2008) Role of CYP1B1 in glaucoma. Annual Review of Pharmacology and Toxicology 48: 333–358.

Vitart V, Bencic G, Hayward C et al. (2010) New loci associated with central cornea thickness include COL5A1, AKAP13 and AVGR8. Human Molecular Genetics 19: 4304–4311.

Wiggs JL (2007) Genetic etiologies of glaucoma. Archives of Ophthalmology 125: 30–37.

Williams SE, Whigham BT, Liu Y et al. (2010) Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population. Molecular Vision 16: 705–712.

Winkler CA, Nelson GW and Smith MW (2010) Admixture mapping comes of age. Annual Review of Genomics and Human Genetics 11: 65–89.

Wolfs RC, Klaver CC, Ramrattan RS et al. (1998) Genetic risk of primary open‐angle glaucoma. Population‐based familial aggregation study. Archives of Ophthalmology 116: 1640–1645.

Zhou Y, Grinchuk O and Tomarev SI (2008) Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma. Investigative Ophthalmology and Visual Science 49: 1932–1939.

Zhu G, Wu CJ, Zhao Y and Ashwell JD (2007) Optineurin negatively regulates TNFalpha‐induced NF‐kappaB activation by competing with NEMO for ubiquitinated RIP. Current Biology 17: 1438–1443.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Liu, Yutao, and Allingham, R Rand(Dec 2010) Genetics of Glaucoma. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0021429]